LabCorp $1.2 billion acquisition of Chiltern

Overview:

• LabCorp has acquired Chiltern for $1.2 billion.
• LabCorp is a health care diagnostics company while Chiltern is a specialty contract research organization that focuses on clinical research.
• After the acquisition LabCorp will become a leading contract research organisation with more than 20,000 employees and leading diagnostics and drug development businesses.
• JPMorgan Securitites and Well Fargo Securities have acted as financial advisers to LabCorp.
• Jefferies has advised Chiltern.

Katrin Kostadinova - Data analyst